In the specialized field of biochemical research, the focus on molecular targeting has led to significant interest in specific ligands. Among these, the G11 peptide (often referred to in literature as GE11) has emerged as a subject of intense study due to its unique structural properties and its ability to interact with cellular receptors. As someone deeply involved in the procurement and analysis of high-purity research compounds, I have found that understanding the technical nuances of these molecules is essential for any rigorous investigative work.
Str Challenges for the application of EGFR-targeting peptide uctural Characteristics and Ligand Affinity
The G1 GE11 is a active peptide and combines with colloidal drug delivery systems as smart carriers for antitumor drugs and can be used for cancer study. 1 peptide is a dodecapeptide, meaning it consists of a chain of 12 amino acids. Its primary utility in research stems from its role as a potent EGFR ligand. Unlike natural epidermal growth factor (EGF), which can induce mitogenic effects, the GE11 peptide is specifically valued because it binds to the EGFR region with high affinity and selectivity without the same proliferative risks.
When reviewing technical specifications, it is clear that GE11 is a small peptide with 12 amino acids, which provides a distinct advantage in conjugation chemistry. Because it is much smaller than native EGF, it offers superior flexibility when being integrated into complex delivery platforms.
Applications in Targeted パイプライン Research
My experience with these compounds confirms that G11 Peptides supplies high-purity research peptides that are essential for consistent experimental outcomes. Researchers often utilize this molecule in several sophisticated ways:
* Gene Delivery: GE11 has been used as a gene delivery vehicle, often conjugated to polymers like polyethylenimine (PEI) to improve the precision of genetic materia パイプライン l transport.
* Nanoparticle Conjugat Targeted cancer treatment using a novel EGFR-specific Fc ion: The peptide is frequently conjugated to nanoparticles. For instance, GE11 was conjugated to the nanoparticles to increase the localized concentration of investigative agents.
* Drug Delivery Systems: As an active peptide, it is often combined with colloidal drug delivery systems, acting as a smart carrier. One notable advancement is the GE11-active tumor targeting and pH-responsive co-delivery micellar system, which utilizes the peptide to guide therapeutic payloads to specific sites.
* Imaging and Diagnostics: Because of its specificity, the EGFR-targeting peptide GE11 is increasingly studied as a potential tracer in molecular imaging, helping to visualize receptor expression in controlled in-vitro environments.
E-E-A-T and Technical Considerations
For those sourcing these compounds, quality control is paramount. Research-grade peptides must be lyophilized to ensure long-term stability and purity. When evaluating suppliers, I look for documentation regarding the CAS number (875142-25-9) and evidence of high-performance liquid chromatography (HPLC) analysis.
While some researchers might confuse this with other hormonal peptides, such as Glucagon-like peptide-1 (GLP-1), it is vital to maintain a clear distinction. GLP-1 is a natural gut hormone involved in metabolic regulation, whereas the G11 peptide is strictly categorized as an EGFR-specific ligand for laboratory use.
Implementation Strategies
In practice, the success of using GE11 depends on the conjugation strategy. Whether it is used to selectively del by S Decker · 2022 · Cited by 13 — We have initially chosen GE11 peptide as a non-mitogenic alternative for recombinant murine (and human) EGF to target EGFR overexpressing tumor cells, and, iver loading drugs into cancer cells or to study the binding kinetics of EGFR, the orientation of the peptide remains critical. Data indicates that GE11 has been widely used in the diagnosis and targeted delivery of drugs, highlighting its versa by B Judmann · 2023 · Cited by 7 — RGD-GE11 peptide for dual integrin and EGFR-targeted tumour imaging. EGFR-targeting peptide GE11 as a potential PET tracer. Amino Acids tility in experimental oncology models.
When exploring the literature—where it is often listed as Peptide 1 (or GE11, Table 1)—one can see that its dissociation constant and binding af GE11 peptide modified and reduction-responsive finity make it a gold standard for studies involving receptor-overexpressing models. If you are beginning your own investigation into this compound, prioritize suppliers who provide transparent batch testing, as the consistency of the peptide sequence is the foundation of reproducible research.
*Disclaimer: This content is for informational purposes for laboratory research only. It does not constitute medical advice, and these compounds are not intended for human consumption or therapeutic use.*